Skip to main content
PAS 2024 Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Pre-Conference Ticketed Event
Pre-Conference Ticketed Event
APA Award Winner
APA Award Winner
APS Award Winner
APS Award Winner
ASPN Award Winner
ASPN Award Winner
SPR Award Winner
SPR Award Winner
On Demand Presentation
On Demand Presentation
Poster Icons
SPR Award Winner
SPR Award Winner
Back
Evaluation ViewAttendees 30

Emergency Medicine

Session: Emergency Medicine 2

Impact of Arginine Therapy on Mitochondrial Function, Oxidative Stress and Clinical Outcomes in Children with Sickle Cell Disease and Vasoocclusive Pain: A Phase-2 Randomized Controlled Trial

Saturday, May 4, 2024
3:00 PM – 3:15 PM ET
Location: Metro Toronto Convention Centre: 202
CE Enduring CME: 0.25
Publication Number: 2045.5
Claudia R.. Morris, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, United States; Nitya Bakshi, Yale University, New Haven, CT, United States; Deborah L. Leake, Children's Healthcare of Atlanta, Atlanta, GA, United States; Scott Gillespie, Emory University School of Medicine, Atlanta, GA, United States; Lou Ann S. Brown, Emory University, Atlanta, GA, United States; Frank Harris, Emory University, Atlanta, GA, United States; Chris A. Rees, Emory University School of Medicine, ATLANTA, GA, United States; Dunia Hatabah, Emory University, atlanta, GA, United States; Rawan Korman, Emory University School of Medicine, Atlanta, GA, United States; Mark Griffiths, Emory University School of Medicine, Atlanta, GA, United States; Sruti Shiva, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States; Carlton Dampier, Emory University School of Medicine, Atlanta, GA, United States

    Presenting Author(s)

  • Claudia Morris, MD (she/her/hers)

    Professor of Pediatrics and Emergency Medicine
    Emory University School of Medicine; Children's Healthcare of Atlanta
    Atlanta, Georgia, United States

    Slides
Disclosure(s):
Claudia Morris, MD: CSL Behring (Ongoing) (Products/Services: Consultant); Food as Medicine Therapeutics LLC (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); Roche (Ongoing) (Products/Services: Consultant); Trility Life Sciences (Ongoing) (Products/Services: Advisory Committee, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); UCSF-Benioff Children's Hospital Oakland (Ongoing) (Products/Services: Intellectual Property including patent beneficiary and royalties); UpToDate (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds)